A European manager recommends Aston AstraZeneca
A senior official of the European Medicines Agency (EMA) said in an interview on Sunday that it would be better to stop the Astrogenogen vaccine against Covit-19 for all ages when alternative medicines are available. Marco Gavaleri, head of vaccination strategy at EMA, told the Italian newspaper Print The Johnson & Johnson vaccine should be used by people over 60 years of age. Both of these virus vector vaccines have been approved by the European regulator for people over 18, but are said to have rare blood clots.
Asked if it would be better to ban AstraZeneca, including those over 60, Marco Cavaleri replied: “Yes, many countries, such as France and Germany, have an option to consider increasing messenger RNA vaccines.” “However, incidents are very rare, first. It is true that there is less data on the second dose, but in the UK it (the vaccination program) is doing well. ”
“In young people, the risk of getting sick is reduced, and for them the message may be to use messenger RNA vaccines, but the choice is left to each state,” he said.